Skip to main content
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
82.28
-1.18 (-1.41%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Edwards Lifesciences Revenue

Edwards Lifesciences had revenue of $1.65B in the quarter ending March 31, 2026, with 16.70% growth. This brings the company's revenue in the last twelve months to $6.30B, up 14.15% year-over-year. In the year 2025, Edwards Lifesciences had annual revenue of $6.07B with 11.55% growth.

Revenue (ttm)
$6.30B
Revenue Growth
+14.15%
P/S Ratio
7.53
Revenue / Employee
$393,969
Employees
16,000
Market Cap
47.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.07B628.10M11.55%
Dec 31, 20245.44B429.50M8.57%
Dec 31, 20235.01B546.00M12.23%
Dec 31, 20224.46B-768.50M-14.69%
Dec 31, 20215.23B846.20M19.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Abbott Laboratories 45.13B
Medtronic 35.48B
Stryker 25.12B
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Boston Scientific 20.61B
Zimmer Biomet Holdings 8.41B
Smith & Nephew 6.16B
Revenue Rankings

EW News

More News